GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

Kodu・Aktsiate loetelu・Haleon PLC
Search

Haleon PLC

Suletud

SektorTervishoid

343.7 1.06

Osta

Hinna uuendus 1. mai 2026, 15:29 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

341.1

Max

343.8

Põhinäitajad

By Trading Economics

Sissetulek

403M

Müük

2.7B

P/E

Sektori keskmine

17.216

51.415

Aktsiakasum

0.044

Dividenditootlus

2.14

Kasumimarginaal

14.708

Töötajad

24,535

EBITDA

697M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+29.65% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.14%

2.34%

Järgmine tulemuste avaldamine

30. juuli 2026

Järgmine aktsia dividendi kuupäev (ex-date)

13. aug 2026

Turustatistika

By TradingEconomics

Turukapital

29B

Eelmine avamishind

342.64

Eelmine sulgemishind

343.7

Uudiste sentiment

By Acuity

46%

54%

144 / 345 Pingereas Healthcare

Haleon PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

29. apr 2026, 07:48 UTC

Tulu

Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

DJ

Loe

29. apr 2026, 06:39 UTC

Tulu

Sensodyne-maker Haleon Revenue Rises on Oral Health Growth

DJ

Loe

25. veebr 2026, 07:55 UTC

Tulu

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

DJ

Loe

29. apr 2026, 08:05 UTC

Market Talk
Tulu

Haleon's North America Results Were Encouraging -- Market Talk

DJ

Loe

29. apr 2026, 07:46 UTC

Market Talk
Tulu

Haleon's First-Quarter Results Align With Peers -- Market Talk

DJ

Loe

29. apr 2026, 06:07 UTC

Tulu

Haleon: 1Q Emerging Markets Revenue Growth 4.3%

DJ

Loe

29. apr 2026, 06:06 UTC

Tulu

Haleon: Q1 North America Organic Revenue Growth 1.0%

DJ

Loe

29. apr 2026, 06:05 UTC

Tulu

Haleon 1Q Reported Revenue Growth 0.1%

DJ

Loe

29. apr 2026, 06:04 UTC

Tulu

Analysts Saw Haleon 1Q Organic Revenue Growth 2.3%

DJ

Loe

29. apr 2026, 06:04 UTC

Tulu

Haleon 1Q Organic Revenue Growth 2.2%

DJ

Loe

29. apr 2026, 06:04 UTC

Tulu

Haleon 1Q Rev GBP2.86B

DJ

Loe

29. apr 2026, 06:04 UTC

Tulu

Haleon Sees High-single Digit Adjusted Operating Profit Growth at Constant Currency in Medium Term

DJ

Loe

29. apr 2026, 06:03 UTC

Tulu

Haleon Sees 4% to 6% Organic Rev Growth in Medium Term

DJ

Loe

29. apr 2026, 06:03 UTC

Tulu

Haleon Expects a Broadly Neutral Foreign Exchange Translation Impact on Net Rev, Adj Oper Pft

DJ

Loe

29. apr 2026, 06:02 UTC

Tulu

Haleon Sees 2026 Adjusted Effective Tax Rate c.24.5%

DJ

Loe

29. apr 2026, 06:02 UTC

Tulu

Haleon: Sees 2026 Net Interest GBP255 Million

DJ

Loe

29. apr 2026, 06:02 UTC

Tulu

Haleon Sees 2026 High-single Digit Adj Oper Pft Growth at Constant Currency

DJ

Loe

29. apr 2026, 06:01 UTC

Tulu

Haleon Sees 2026 Organic Revenue Growth 3% to 5%

DJ

Loe

25. veebr 2026, 07:18 UTC

Tulu

Haleon 4Q Organic Revenue Growth 2.1%

DJ

Loe

25. veebr 2026, 07:17 UTC

Tulu

Haleon: GBP500M Allocated to Share Buybacks in 2026

DJ

Loe

25. veebr 2026, 07:16 UTC

Tulu

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

DJ

Loe

25. veebr 2026, 07:15 UTC

Tulu

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

DJ

Loe

25. veebr 2026, 07:06 UTC

Tulu

Haleon Declares Final Dividend of 4.9p

DJ

Loe

25. veebr 2026, 07:05 UTC

Tulu

Haleon 2025 Net Pft GBP1.67B

DJ

Loe

25. veebr 2026, 07:05 UTC

Tulu

Haleon 2025 Pretax Pft GBP2.15B

DJ

Loe

25. veebr 2026, 07:04 UTC

Tulu

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

DJ

Loe

25. veebr 2026, 07:04 UTC

Tulu

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

DJ

Loe

25. veebr 2026, 07:04 UTC

Tulu

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

DJ

Loe

25. veebr 2026, 07:04 UTC

Tulu

Analysts Saw Haleon 2025 Rev at GBP11.03B

DJ

Loe

25. veebr 2026, 07:04 UTC

Tulu

Haleon 2025 Adj. Operating Pft Margin 22.9%

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Haleon PLC Prognoos

Hinnasiht

By TipRanks

29.65% tõus

12 kuu keskmine prognoos

Keskmine 426.67 GBX  29.65%

Kõrge 512 GBX

Madal 325 GBX

Põhineb 10 Wall Streeti analüütiku instrumendi Haleon PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

7

Osta

2

Hoia

1

Müü

Põhineb 10 analüütiku instrumendi Haleon PLC aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

144 / 345 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Muud aktsiad sektorist

GSK

GlaxoSmithKline PLC

1,858.5

↓-0.83%
help-icon Live chat